Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial

https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00305-7/fulltext?dgcid=raven_jbs_etoc_feature_lanmic